Can we further SPARkle the SPAR model?
- PMID: 29959182
- DOI: 10.1136/annrheumdis-2018-213954
Can we further SPARkle the SPAR model?
Keywords: methotrexate; systemic sclerosis; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Can we further SPARkle the SPAR model?' by Kavadichanda et al.Ann Rheum Dis. 2019 Sep;78(9):e94. doi: 10.1136/annrheumdis-2018-213962. Epub 2018 Jul 21. Ann Rheum Dis. 2019. PMID: 30032115 No abstract available.
Comment on
-
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model.Ann Rheum Dis. 2018 Sep;77(9):1326-1332. doi: 10.1136/annrheumdis-2018-213201. Epub 2018 Jun 6. Ann Rheum Dis. 2018. PMID: 29875097
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical